^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Orplatna (satraplatin)

    i
    Associations
    News

    Trials

    Company:
    Agennix, Assertio, BMS, Yakult Honsha
    Drug class:
    Alkylating agent
    Related drugs:
    Associations
    News

    Trials

    Apply
    Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors (NCT01259479)
    Phase 1
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    07/05/2018
    Initiation :
    12/03/2010
    Primary completion :
    08/01/2013
    Completion :
    05/29/2015
    AFP
    |
    cisplatin • Orplatna (satraplatin)
    Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca (NCT01289067)
    Phase 2
    William K. Oh
    Completed
    Last update posted :
    02/13/2018
    Initiation :
    12/01/2010
    Primary completion :
    05/01/2013
    Completion :
    05/01/2013
    BRCA
    |
    docetaxel • Orplatna (satraplatin)